SCHEMBL8544580

SCHEMBL8544580

COc1ccc2[nH]cc(CCNC=O)c2c1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 4/20 0.47
MTNR1B P49286 4/20 0.47
NQO2 P16083 1/20 0.47
HTR1A P08908 4/20 0.43
HTR2A P28223 5/20 0.41
HTR6 P50406 5/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
NFKB1 P19838 1/20 0.40
MAPK1 P28482 1/20 0.40
SLC6A4 P31645 1/20 0.40
CYP2C19 P33261 1/20 0.40
THPO P40225 1/20 0.40
HTR2B P41595 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8544722 0.85 HTR2A (0.53) MTNR1AMTNR1BNQO2HTR1AHTR2A
SCHEMBL8549023 0.84 MPO (0.48) MTNR1AMTNR1BNQO2HTR1AHTR2A
SCHEMBL19386209 0.82 MTNR1A (0.67) MTNR1AMTNR1BNQO2HTR1AHTR2A
SCHEMBL8545111 0.82 MTNR1A (0.53) MTNR1AMTNR1BNQO2HTR1AHTR2A
Fumaric Acid SCHEMBL8545085 0.80 MTNR1A (0.46) MTNR1AMTNR1BNQO2HTR1AHTR2A
Fumaric Acid SCHEMBL8545087 0.80 MTNR1A (0.46) MTNR1AMTNR1BNQO2HTR1AHTR2A
SCHEMBL8545108 0.80 MTNR1A (0.55) MTNR1AMTNR1BNQO2ABCG2MEN1
SCHEMBL2541508 0.79 HTR2A (0.65) HTR1AHTR2AHTR6MEN1CYP1A2
SCHEMBL8543450 0.76 HTR1A (0.71) MTNR1AMTNR1BHTR1AHTR2AHTR6
SCHEMBL2535287 0.76 ALDH1A1 (0.48) MTNR1AMTNR1BLMNACYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0593513-B1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES SMITHKLINE BEECHAM PLC (GB) 1998-10-28 EP disclosed
US-5571833-A TREATMENT OF MIGRAINE, PORTAL HYPERTENSION SMITHKLINE BEECHAM PLC (GB) 1996-11-05 US disclosed
EP-0593513-A1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES SMITHKLINE BEECHAM PLC (GB) 1994-04-27 EP disclosed
WO-1993000333-A1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE OR 5-HT2 RECEPTOR AGONISTS SMITHKLINE BEECHAM PLC (GB) 1993-01-07 WO disclosed